Bentham Science Logo

Track Your Manuscript:


Current Pharmaceutical Biotechnology

Volume 21, 15 Issues, 2020
ISSN: 1873-4316 (Online)
ISSN: 1389-2010 (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

Contents

Current Pharmaceutical Biotechnology, Volume 13 - Number 9








Pro-Oncogenic Cell Signaling Machinery as a Target for Oncolytic Viruses

, 13(9): 1742 - 1749

Emma Borrego-Diaz, Rajesh Mathew, Dana Hawkinson, Tuba Esfandyari, Zhengian Liu, Patrick W Lee and Faris Farassati


DOI: 10.2174/138920112800958788


Oncolytic Viruses for Induction of Anti-Tumor Immunity

, 13(9): 1750 - 1760

Alex W. Tong, Neil Senzer, Vincenzo Cerullo, Nancy Smyth Templeton, Akseli Hemminki and John Nemunaitis


DOI: 10.2174/138920112800958913






The Molecular Basis of Herpesviruses as Oncolytic Agents

, 13(9): 1795 - 1803

Laura Menotti, Gabriella Campadelli-Fiume, Patrizia Nanni, Pier Luigi Lollini and Carla De Giovanni


DOI: 10.2174/138920112800958931





Recent Clinical Experience with Oncolytic Viruses

, 13(9): 1834 - 1841

O. G. Donnelly, F. Errington-Mais, R. Prestwich, K. Harrington, H. Pandha, R. Vile and A. A. Melcher


DOI: 10.2174/138920112800958904





Editor-in-Chief

Nikolaos Labrou
Department of Biotechnology
Agricultural University of Athens
Athens
(Greece)

Biography View Full Editorial Board

Journal History

Current Pharmaceutical Biotechnology was launched in 2000. Dr. Nikolaos Labrou serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.97

Advertisement

Covid Resource CenterCoronaviruses-JOIN-EDITORIAL-BOARD

Related Journals

Related eBooks

eBooks Catalog